Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVANTI: Pecavaptan in Heart Failure
NCT03901729Phase 2Completed
- Sponsor
- Bayer
- Start
- May 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of pecavaptan in heart failure (HF), sponsored by Bayer. Started May 2019; status: completed.
02
Drugs
pecavaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03901729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03901729.